DBS: Cycling Deep Brain Stimulation on Parkinson's Disease Gait

Sponsor
University of Sao Paulo General Hospital (Other)
Overall Status
Unknown status
CT.gov ID
NCT04408573
Collaborator
(none)
30
1
4
18.3
1.6

Study Details

Study Description

Brief Summary

Our hypothesis is that cycling DBS stimulation would be superior or non-inferior to regular DBS stimulation in Parkinson's disease patients with gait impairment. The objective of this study is compare gait disorders in patients with Parkinson's disease and DBS in 4 different scenarios: 1) regular continuous high frequency (>130Hz) stimulation, 2) cycling high frequency (>130Hz) stimulation (40sec on, 2sec off), 3) low-frequency (80Hz) continuous stimulation and 4) cycling low frequency (80Hz) stimulation (40sec on, 2sec off)

Condition or Disease Intervention/Treatment Phase
  • Other: Cycling deep brain stimulation
N/A

Detailed Description

Gait disorders such as falls, freezing of gait, reduction of speed, shuffling, and multi-stepped turning are common in patients with moderate and advanced Parkinson's disease. Compared to appendicular symptoms (bradykinesia, tremor, and rigidity), gait disorders tend to be more resistant to medical and regular deep brain stimulation treatment, and greatly impairs patients' quality of life and daily living activities. Some stimulation strategies have been tried to improve gait in Parkinson's disease patients, but so far most of them resulted in concomitant worsening of appendicular symptoms. However, new stimulation strategies such as cycling stimulation can potentially improve gait disorders without impairment of appendicular symptoms.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
30 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Intervention Model Description:
2 weeks of regular continuous high frequency (>130Hz) stimulation, 2 weeks of cycling high frequency (>130Hz) stimulation (40sec on, 2sec off), 2 weeks of low-frequency (80Hz) continuous stimulation and 2 weeks of cycling low frequency (80Hz) stimulation (40sec on, 2sec off)2 weeks of regular continuous high frequency (>130Hz) stimulation, 2 weeks of cycling high frequency (>130Hz) stimulation (40sec on, 2sec off), 2 weeks of low-frequency (80Hz) continuous stimulation and 2 weeks of cycling low frequency (80Hz) stimulation (40sec on, 2sec off)
Masking:
Triple (Participant, Care Provider, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Effects of Cycling Deep Brain Stimulation on Parkinson's Disease Gait
Actual Study Start Date :
Jun 19, 2020
Anticipated Primary Completion Date :
May 29, 2021
Anticipated Study Completion Date :
Dec 29, 2021

Arms and Interventions

Arm Intervention/Treatment
No Intervention: Regular Continuous High Frequency

Patient remains 2 weeks in the currently chosen stimulation protocol.

Experimental: Cycling High Frequency

Patient is stimulated with the same polarity, voltage/current, pulse width and frequency as the currently chosen stimulation protocol, but with cycling stimulation: 40sec On - 02 sec OFF

Other: Cycling deep brain stimulation
Deep Brain Stimulation applied in cycling - periods of stimulation ON intercalated with periods of stimulation OFF

Experimental: Continuous Low Frequency

Patient is stimulated with the same polarity and pulse width as the currently chosen stimulation protocol, but with low frequency (80Hz). Voltage/current will be adjusted to maintain TEED similar to that on the regular stimulation protocol.

Other: Cycling deep brain stimulation
Deep Brain Stimulation applied in cycling - periods of stimulation ON intercalated with periods of stimulation OFF

Experimental: Cycling Low Frequency

Patient is stimulated with the same polarity and pulse width as the currently chosen stimulation protocol, but with low frequency (80Hz) and cycling stimulation: 40sec On - 02 sec OFF. Voltage/current will be adjusted to maintain TEED similar to that on the regular stimulation protocol.

Other: Cycling deep brain stimulation
Deep Brain Stimulation applied in cycling - periods of stimulation ON intercalated with periods of stimulation OFF

Outcome Measures

Primary Outcome Measures

  1. Change in the part II of the Unified Parkinson's disease rating scale [Baseline + after 2 weeks + after 4 weeks + after 6 weeks]

    The part II of the Unified Parkinson's disease rating scale (UPDRS II) is a self-reportable questionnaire consisting of 13 items that measure functionality (motor experiences of daily living). Scores vary from 0 - 52. Higher scores mean a worse outcome.

  2. Change in the New Freezing of Gait Questionnaire [Baseline + after 2 weeks + after 4 weeks + after 6 weeks]

    The New Freezing of Gait Questionnaire (NFOG-Q) is a self-reportable questionnaire consisting of 9 items that measure freezing of gait (FOG). Scores vary from 0 - 28. Higher scores mean a worse outcome.

Secondary Outcome Measures

  1. Change in Falls Efficacy Scale [Baseline + after 2 weeks + after 4 weeks + after 6 weeks]

    The Falls Efficacy Scale (FES) is a sixteen-item test rated on a 10-point scale from not confident at all to completely confident. It is correlated with difficulty getting up from a fall and level of anxiety. Scores vary from 16 - 64. Higher scores mean a worse outcome.

  2. Change in The Parkinson's Disease Questionnaire (PDQ-39) [Baseline + after 2 weeks + after 4 weeks + after 6 weeks]

    This questionnaire assesses how often people affected by Parkinson's experience difficulties across 8 dimensions of daily living. The 39 item questionnaire offers a patient reported measure of health status and quality of life and is the most frequently used disease-specific health status measure.Scores vary from 0 - 156. Higher scores mean a worse outcome.

  3. Change in Activities-Specific Balance Confidence Scale (ABC scale) [Baseline + after 2 weeks + after 4 weeks + after 6 weeks]

    The ABC scale is a self-report measure of balance in performing various activities without losing balance or experiencing a sense of unsteadiness. Scores vary from 0 - 100. Higher scores mean a better outcome.

  4. Number of falls [Baseline + after 2 weeks + after 4 weeks + after 6 weeks]

    Patients will be questioned about number of times they experienced falls in the last 2 weeks. Higher numbers mean a worse outcome.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Diagnosis of idiopathic Parkinson's disease

  • Currently receiving Deep Brain Stimulation as a Parkinson's disease treatment

  • Hoehn & Yahr stage between 2-4 during off-medication

  • Underlying gait disorders despite optimal medical and stimulation treatment: score over or equal to 1 in the subitem 2.12 of the MDS-UPDRS scale

  • Willingness to comply with all study procedures

Exclusion Criteria:
  • Active moderate/severe psychiatric condition

  • Active infection or other uncontrolled moderate/grave comorbidities

  • Treatment with experimental drug

  • Pregnancy or breast-feeding

Contacts and Locations

Locations

Site City State Country Postal Code
1 Hospital das Clínicas da Faculdade de Medicina da USP São Paulo SP Brazil 05403000

Sponsors and Collaborators

  • University of Sao Paulo General Hospital

Investigators

  • Principal Investigator: Rubens G Cury, MD, PhD, University of Sao Paulo General Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Rubens Gisbert Cury, Principal Investigator, University of Sao Paulo General Hospital
ClinicalTrials.gov Identifier:
NCT04408573
Other Study ID Numbers:
  • 67914017.6.0000.0068
First Posted:
May 29, 2020
Last Update Posted:
Jun 23, 2020
Last Verified:
Jun 1, 2020
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 23, 2020